Aethlon Medical has 1,604,095 common shares outstanding after recent exercises removed every pre-funded Warrant that had remained unexercised. For investors, the update establishes the company’s common-stock count at the close of Business on August 28 and confirms that no pre-funded warrants remain outstanding.

Key Highlights

  • Every previously unexercised pre-funded warrant has now been exercised.
  • Aethlon Medical measured its common-stock total at the August 28 close of business.
  • Chief Executive Officer and Chief Financial Officer James B. Frakes signed the update on August 31, 2026.

AETHLON MEDICAL INC (NASDAQ: AEMD) had 1,604,095 shares of common stock outstanding at the close of business on August 28, following recent exercises of pre-funded warrants. Every pre-funded warrant that had previously remained outstanding was exercised.

All Pre-Funded Warrants Exercised

The updated share count covers Aethlon Medical’s common stock. The company tied the figure to the end of business on August 28, 2026. The exercises completed the conversion of all previously outstanding pre-funded warrants.

James B. Frakes signed the update for Aethlon Medical on August 31, 2026, in his roles as chief executive officer and chief financial officer.